The Big4Bio Company to Watch Program
July 2021: Meissa Vaccines

THE COMPANY/THE MISSION Meissa Vaccines Is Driven to Rid the World of Viral Respiratory Scourges Meissa Vaccines is on a mission to solve a puzzle that has eluded scientists for decades—a pediatric vaccine against respiratory syncytial virus, or RSV.     THE PIPELINE Building Single Dose, Intranasal Vaccines to Prevent COVID-19 and RSV Making vaccines […]

Read More

The Big4Bio Company to Watch Program
May 2021: Venatorx Pharmaceuticals

THE COMPANY/THE MISSION The Drug Hunter Flying Under the Radar In 2010, Drs. Christopher Burns, Daniel Pevear, and Luigi Xerri set out to build a company focused on anti-infectives; they named it Venatorx, which loosely translated means “Drug Hunter.”   THE PIPELINE Addressing the Next Pandemic: Superbugs Venatorx’s lead clinical-stage antibiotics address the growing problem […]

Read More

SPOTLIGHT: Big4Bio:San Diego 2020 Year-in-Review

Welcome to the 2020 Big4Bio Year-in-Review for the San Diego region! We hope you enjoy looking back on 2020’s top stories, deals, and M&A that went down in San Diego’s research, pharma, and biotech sectors as we head into 2021. Here’s what you’ll find inside the Year-in-Review 2020 report: Facts about San Diego’s life sciences […]

Read More

Spotlight Q&A: TFF Pharmaceuticals – Innovative Drug Formulation May Expand Geographic Reach of COVID-19 Vaccines and Treatments

LaVoieHealthScience Client Spotlight Following is a Q&A with Glenn Mattes, President, CEO and Director of TFF Pharmaceuticals (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform. Welcome to Big4Bio, Mr. Mattes. Can you share with our readers what is important about […]

Read More

Spotlight: Sikich — A Formula for Life Science Success

Sikich LLP is a 1000 member business advisory firm that offers technology and accounting services to a broad array of companies. In operation for more than 35 years, about 10 years ago the company started offering its services to life sciences companies, tailored to fit their specific needs. Big4Bio editor Marie Daghlian recently met virtually […]

Read More

Spotlight: Explora BioLabs — Powering Your Science

Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]

Read More

Big4Bio:San Diego COVID-19 Resource Page

With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]

Read More

SPOTLIGHT: Big4Bio:San Diego 2019 Year-in-Review

Welcome to the first-ever Big4Bio Year-in-Review for the San Diego region! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in San Diego’s research, pharma, and biotech industries as you look towards a productive 2020. The 2019 Year-in-Review report includes: Facts/data about the San Diego life sciences market […]

Read More

Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy

Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]

Read More

Spotlight: Q&A With Scott Grossman on ExL Events

ExL Events, a division of Questex, develops and hosts content-driven conferences and partnered events for life sciences industry professionals and academia that cover a breadth of topics from drug and device development issues and services, to hospital networks, communications, and human resources.  Their diverse event portfolio is backed by extensive market research and targeted outreach […]

Read More

An Update on Big4Bio’s LinkedIn Groups

As Big3Bio rebrands to Big4Bio, the organization’s LinkedIn presence will also be reshaped. LinkedIn groups have the potential to instigate meaningful discussions among members of the community. In the past, Big3Bio has cultivated three region–specific groups, Boston, San Diego, and SFBay. But with Big3Bio rebranding to Big4Bio, we have made the decision to unify the […]

Read More

Spotlight: Big3Bio Announces Upcoming Launch of Philadelphia as a New Region of Coverage; Will Rebrand as Big4Bio

– Big4Bio:Philly to Recap Life Science Developments in the Greater Philadelphia Region; To Launch During BIO International Convention in Philadelphia in June – All “Big3Bio” Regional Sites of Boston, SFBay, San Diego to Come Together Into New “Big4Bio.com” Website With Philadelphia to Be Included BigBio Communications is proud to announce the upcoming expansion and rebranding […]

Read More

Spotlight: Advance Biotech Grant Program

Unlock your molecule’s potential. Apply to the US and Canada Advance Biotech Grant Program Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 6th edition, is open to biotech start-up companies in US and Canada to help you accelerate to clinic faster. Apply now for a chance to win […]

Read More

California Life Sciences Industry Report Highlights Continued Strong Growth

BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports, special features and more. Today’s feature is a Q&A with Sara Radcliffe, President & CEO, California Life Sciences […]

Read More